Status:
NOT_YET_RECRUITING
A Real-World Study on Extranodal Lymphoma
Lead Sponsor:
Ruijin Hospital
Conditions:
Lymphoma
Lymphoma, B-Cell
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to prospectively collect clinical information on patients with extranodal lymphoma, and to explore the best therapeutic strategies in the real-world population.
Detailed Description
Lymphoma is a common hematological malignancy. Many different pathologic types of lymphoma can originate in extranodal organs or be associated with extranodal organ involvement. For lymphoma with extr...
Eligibility Criteria
Inclusion
- Age ≥ 18 years (including 18 years old).
- Patients newly diagnosed with non-Hodgkin lymphoma with extranodal involvement, whether it is primary, secondary, or cannot be determined.
- Patients who have received systematic clinical treatment.
- Patients with measurable lesions, at least containing one effective evaluation of efficacy.
Exclusion
- Patients who only receive supportive treatment.
- Patients who cannot obtain effective evaluation data of efficacy.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2029
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06573099
Start Date
September 1 2024
End Date
September 1 2029
Last Update
August 27 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.